VanEck Associates’s Crescent Capital BDC CCAP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.81M Buy
165,366
+5,936
+4% +$72.5K ﹤0.01% 1054
2026
Q1
$1.94M Buy
159,430
+763
+0.5% +$10.4K ﹤0.01% 998
2025
Q4
$2.23M Buy
158,667
+5,578
+4% +$79.3K ﹤0.01% 978
2025
Q3
$2.18M Buy
153,089
+59,964
+64% +$898K ﹤0.01% 972
2025
Q2
$1.31M Buy
93,125
+35,952
+63% +$552K ﹤0.01% 1016
2025
Q1
$979K Buy
57,173
+11,611
+25% +$216K ﹤0.01% 1039
2024
Q4
$876K Buy
45,562
+1,006
+2% +$19K ﹤0.01% 1055
2024
Q3
$819K Buy
44,556
+18,035
+68% +$335K ﹤0.01% 1022
2024
Q2
$498K Buy
26,521
+15,288
+136% +$273K ﹤0.01% 1077
2024
Q1
$194K Buy
+11,233
New +$189K ﹤0.01% 1179

Other funds holding CCAP

VanEck Associates's CCAP Position: Q2 2026 in Review

VanEck Associates increased its Crescent Capital BDC (CCAP) stake by 3.7% in Q2 2026, buying an estimated $72.5K and bringing the position to 165,366 shares worth $1.81M. The position accounts for ﹤0.01% of the portfolio, ranked #1054.

VanEck Associates first reported a position in CCAP in Q1 2024 and has held it in 10 quarters since. The position peaked at $2.23M in Q4 2025. 85 funds tracked by Wall St. Rank hold CCAP as of Q2 2026.

  • VanEck Associates held 165,366 shares of Crescent Capital BDC worth $1.81M as of Q2 2026.
  • VanEck Associates bought 5,936 Crescent Capital BDC shares in Q2 2026, an estimated $72.5K.
  • Crescent Capital BDC made up ﹤0.01% of VanEck Associates's portfolio in Q2 2026, its #1054 holding.
  • VanEck Associates first reported a position in Crescent Capital BDC in Q1 2024 and has held it in 10 quarters since.
  • VanEck Associates's Crescent Capital BDC position peaked at $2.23M in Q4 2025.
  • 85 funds tracked by Wall St. Rank held Crescent Capital BDC as of Q2 2026.

Based on VanEck Associates's 13F filing for Q2 2026, filed 14 Aug 2026.